Sunrise Medical ApS: Financial statements 2023
CVR: 37005665
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Sunrise Medical ApS (CVR 37005665) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 11,738,848 and a net result of DKK 1,408,512 compared with DKK 857,415 the year before. That is an increase of 8.6% compared with the year before. Equity in the 2023 report amounted to DKK 4,665,771. The solvency ratio was 31.4%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 11,738,848
- Profit/Loss
- DKK 1,408,512
- Equity
- DKK 4,665,771
- Total Assets
- DKK 14,866,880
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 11.7M | 1.4M | 4.7M | 16 |
| 2022 | - | 10.8M | 857K | 3.3M | 16 |
| 2021 | - | 10M | -622K | 2.4M | 16 |
| 2020 | - | 8.9M | -3.3M | 3M | 19 |
| 2019 | - | 10.9M | -2.8M | 3.5M | 20 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Sunrise Medical ApS
Sunrise Medical ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Adrian John Platt and James Louis Barratt. The board consists of Adrian John Platt (chair) and James Louis Barratt. The company is owned by Cidron Ollopa B.V.. The company has 22 employees (2026). In 2024, the company reported a gross profit of DKK 12,726,030 and a net result of DKK 1,921,194 compared with DKK 1,408,512 the year before. Equity in the 2024 report amounted to DKK 6,586,965.
